Weijing decoction

a mixture of four herbs including Rhizoma Phragmitis (Lu Gen) (60 g), Semen Coicis (Yi Yi Ren) (30 g), Semen Persicae (Tao Ren) (24 g) and Semen Benincasae (Dong Gua Zi) (60 g) at a ratio of 10:5:4:10 (w/w/w/w)

Networked: 8 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Cheng, Jinguo: 2 articles (01/2021 - 12/2020)
2.	Ye, Ren: 2 articles (01/2021 - 12/2020)
3.	Yuan, Zhengzhong: 2 articles (01/2021 - 12/2020)
4.	Zeng, Congcong: 2 articles (01/2021 - 12/2020)
5.	Zhu, Jiahui: 2 articles (01/2021 - 12/2020)
6.	Guo, Xinfeng: 2 articles (08/2019 - 01/2014)
7.	Liu, Shaonan: 2 articles (08/2019 - 01/2014)
8.	Cui, Ge-Dan: 1 article (12/2022)
9.	Gao, Yong-Xiang: 1 article (12/2022)
10.	He, Li-Sha: 1 article (12/2022)

Related Diseases

1.	COVID-19 12/23/2020 - "We aimed to test our expectation that additional administration of Traditional Chinese medicine (TCM), maxingshigan-weijing decoction, is more effective in the management of COVID-19 patients compared to those treated with routine supportive care alone. " 01/01/2021 - "Therapeutic effects of traditional Chinese medicine (Maxingshigan-Weijing Decoction) on COVID-19: An open-label randomized controlled trial."
2.	Lung Neoplasms (Lung Cancer) 01/01/2021 - "Weijing decoction (WJD), which is a classic ancient Chinese herbal prescription, has been used successfully to treat pulmonary system diseases containing lung cancer in the clinic. "
3.	Pneumonia (Pneumonitis) 12/01/2022 - "During the Novel Coronavirus epidemic in 2020, the Weijing Decoction and Wuye Lugen Decoction, with Rhizoma phragmitis as the main herbal component, were included in The Pneumonia Treatment Protocol for Novel Coronavirus Infection (Trial Version 5) due to remarkable antiviral effects. " 05/01/2023 - "We aimed to explore the key components and core targets of Weijing decoction (WJD) in treating various lung diseases, namely, pneumonia, chronic obstructive pulmonary disease (COPD), acute lung injury (ALI), pulmonary fibrosis, pulmonary tuberculosis and non-small cell lung cancer (NSCLC), via network pharmacology, molecular docking and some experiments. "
4.	Lung Diseases (Lung Disease) 05/01/2023 - "Combinational study with network pharmacology, molecular docking and preliminary experiments on exploring common mechanisms underlying the effects of weijing decoction on various pulmonary diseases." 01/01/2017 - "MaiMenDong Decoction and WeiJing Decoction (Jin formula) is a traditional Chinese medication that consists of 8 medicinal plants, which recorded in the classical TCM literature Jin Kui Yao Lue and has been utilized in the treatment of lung diseases for hundreds of years in China. " 05/01/2023 - "We aimed to explore the key components and core targets of Weijing decoction (WJD) in treating various lung diseases, namely, pneumonia, chronic obstructive pulmonary disease (COPD), acute lung injury (ALI), pulmonary fibrosis, pulmonary tuberculosis and non-small cell lung cancer (NSCLC), via network pharmacology, molecular docking and some experiments. "
5.	Coronavirus Infections 12/01/2022 - "During the Novel Coronavirus epidemic in 2020, the Weijing Decoction and Wuye Lugen Decoction, with Rhizoma phragmitis as the main herbal component, were included in The Pneumonia Treatment Protocol for Novel Coronavirus Infection (Trial Version 5) due to remarkable antiviral effects. "

Related Drugs and Biologics

1.	maxingshigan
2.	Antiviral Agents (Antivirals)
3.	Therapeutic Uses
4.	Sphingolipids
5.	tricin

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)
2.	Drug Therapy (Chemotherapy)